Literature DB >> 1984036

No association with HLA-DR, -DQ or -DP alleles in Guillain-Barré syndrome.

J Hillert1, P O Osterman, O Olerup.   

Abstract

The distribution of HLA class II alleles in Guillain-Barré syndrome (GBS) has previously been reported only for HLA-DR. We report here the results of genomic typing for HLA-DR, -DQ and -DP allelic variability by restriction fragment length polymorphism analysis in 49 patients with a history of GBS. No association was found to HLA-DR, -DQ or -DP alleles or HLA-DR-DQ haplotypes. Subgrouping of patients according to severity of disease, as measured by disability or muscular weakness, or response to plasmapheresis treatment, also failed to reveal significant associations. These data suggest that HLA class II genes do not confer susceptibility to GBS.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1984036     DOI: 10.1016/0165-5728(91)90088-o

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  4 in total

Review 1.  Antiganglioside antibodies and their pathophysiological effects on Guillain-Barré syndrome and related disorders--a review.

Authors:  Kenichi Kaida; Toshio Ariga; Robert K Yu
Journal:  Glycobiology       Date:  2009-02-24       Impact factor: 4.313

Review 2.  Human Leukocyte Antigen DQB1 (HLA-DQB1) Polymorphisms and the Risk for Guillain-Barré Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Peng-Peng Jin; Li-Li Sun; Bo-Jun Ding; Na Qin; Bin Zhou; Feng Xia; Li Li; Li-Juan Liu; Xue-Dong Liu; Gang Zhao; Wen Wang; Yan-Chun Deng; Shuang-Xing Hou
Journal:  PLoS One       Date:  2015-07-23       Impact factor: 3.240

3.  A report of a probable case of familial Guillain Barre syndrome.

Authors:  Mohammad Barzegar; Amir Hossein Jafari Rouhi; Mehdi Farhoudi; Sara Sardashti
Journal:  Ann Indian Acad Neurol       Date:  2012-10       Impact factor: 1.383

4.  Campylobacter jejuni strains from patients with Guillain-Barré syndrome.

Authors:  B M Allos; F T Lippy; A Carlsen; R G Washburn; M J Blaser
Journal:  Emerg Infect Dis       Date:  1998 Apr-Jun       Impact factor: 6.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.